LifePoint, Inc.
$0.00$0.00 (0.0%)
LifePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
OTC · ICCT · USD
Stock price, earnings
Quote as of Jul 2, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
iCoreConnect Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow iCoreConnect Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
iCoreConnect Inc. develops and markets health insurance portability and accountability act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company offers iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, an add-on for iCoreRx that integrates with state databases to automate prescription drug monitoring; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patient insurance eligibility breakdown to verify their benefits; iCoreClaims for processing and managing claims submitted by policyholders or dental care provider; and iCoreHuddle and iCoreHuddle+, which reveals the revenue potential of each patient. It also provides iCoreCodeGenius, a medical coding reference SaaS solution; iCoreExchange, a HIPAA compliant SaaS email solution using direct protocol that allows doctors to send and receive secure email with attachments to and from other healthcare professionals in the network; iCoreCloud provides the ability to backup on-premise servers and computers to the cloud; iCorePay, a cloud-based financial technology solution designed to streamline the billing and payment processes for healthcare providers; iCoreSecure, a secure SaaS solution that solves privacy concerns; and iCoreIT. In addition, the company offers iCoreVerify provides automated insurance verifications; iCoreVerify+ that combines automation with concierge assistance for verification; and iCoreVerifyPro, it manages all verifications, entering insurance benefits directly into patient charts, ensuring insurance information. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. The company was founded in 1992 and is headquartered in Ocoee, Florida. On June 2, 2025, iCoreConnect Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
LifePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (0.0%)
Healthtech Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
VIA Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
OneLife Technologies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Trevena, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.26% below the high.
$0.00$0.00 (0.0%)
Capital Group Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.12% below the high.
$0.00$0.00 (0.0%)
Infinity Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.15% below the high.
$0.00$0.00 (0.0%)
Accelera Innovations, Inc: Healthcare · Medical - Healthcare Information Services.